Zobrazeno 1 - 10
of 57
pro vyhledávání: '"M, Dowzicky"'
Autor:
Justin S. Hatchimonji, Daniel N. Holena, Ruiying Xiong, Dane R. Scantling, Melissa A. Hornor, Phillip M. Dowzicky, Patrick M. Reilly, Elinore J. Kaufman
Publikováno v:
Surgery.
Damage control laparotomy emphasizes physiologic stabilization of critically injured patients and allows staged surgical management. However, there is little consensus on the optimal criteria for damage control laparotomy. We examined variability bet
Publikováno v:
In Journal of Infection and Public Health February 2020 13(2):334-335
Autor:
Daryl J. Hoban, M. Dowzicky, B. Johnson, Meredith Hackel, J. Johnson, Robert E. Badal, Samuel K. Bouchillon, Stephen P. Hawser
Publikováno v:
International Journal of Infectious Diseases. 16
Autor:
M. Dowzicky, Meredith Hackel, B. Johnson, Robert E. Badal, M. Renteria, Sam Bouchillon, Daryl J. Hoban
Publikováno v:
D63. ADVANCES IN TREATMENT OF RESPIRATORY INFECTIONS.
Publikováno v:
D63. ADVANCES IN TREATMENT OF RESPIRATORY INFECTIONS.
Publikováno v:
D63. ADVANCES IN TREATMENT OF RESPIRATORY INFECTIONS.
staphylococcal and enterococcal pathogens. The Tigecycline Evaluation Surveillance Trial (TEST) determined the in vitro activity against methicillin-resistant Staphylococcus. aureus (MRSA) and vancomycin-resistant Enterococcus spp (VRE) sources. Only
Autor:
M. Renteria, B. Johnson, J. Johnson, M. Dowzicky, Meredith Hackel, Robert E. Badal, Samuel K. Bouchillon, Daryl J. Hoban
Publikováno v:
International Journal of Infectious Diseases. 12
Results from this study show 34.5% (403/1171) of Staphylococcus aureus from Latin America are resistant to three or more drug classes, while 21% (245/1171) are resistant to at least four drug classes. Tigecycline inhibited 100% of all multi-d
Autor:
B. Johnson, Meredith Hackel, Daryl J. Hoban, J. Johnson, M. Renteria, M. Dowzicky, Samuel K. Bouchillon, Robert E. Badal
Publikováno v:
International Journal of Infectious Diseases. 12
Objectives: Tigecycline (TIG) has potent expanded broad spectrum activity against most commonly encountered species responsible for community and hospital acquired infections. The T.E.S.T. program determined the in vitro activity of TIG against Acine
Autor:
B. Johnson, Samuel K. Bouchillon, J. Johnson, Daryl J. Hoban, Meredith Hackel, M. Dowzicky, M. Renteria, Robert E. Badal
Publikováno v:
International Journal of Infectious Diseases. 12
Tigecycline is a novel antimicrobial with expanded broad-spectrum activity from a new class of compounds, the glycylcyclines. Tigecycline inhibits protein synthesis by binding to the 30S ribosomal subunit. Although it is perceived to be bacteriostati
Autor:
J. Johnson, Samuel K. Bouchillon, Daryl J. Hoban, Meredith Hackel, B. Johnson, Robert E. Badal, M. Dowzicky, M. Renteria
Publikováno v:
International Journal of Infectious Diseases. 12
Not all specimen sources are shown: Blood, respiratory and skin contributed to >60% of all specimen sources. Complete data analysis may be obtained at www.testsurveillance.com. MIC 50/90 values and % Susceptible are not presented for n's